Event Details

KemPharm® is a rare disease therapeutics company focused on the discovery, development and commercialization of novel treatments for rare CNS and neurodegenerative diseases, lysosomal storage disorders and related treatment areas.

H.C. Wainwright 24th Annual Global Investment Conference

Sep 12, 2022 at 7:00 AM EDT